Equilibrium binding of daunomycin and adriamycin to calf thymus DNA. Temperature and ionic strength dependence of thermodynamic parameters
- PMID: 3377816
- DOI: 10.1016/0006-2952(88)90571-0
Equilibrium binding of daunomycin and adriamycin to calf thymus DNA. Temperature and ionic strength dependence of thermodynamic parameters
Abstract
Absorbance and fluorescence quenching monitoring of the binding of the anthracyclines adriamycin (ADM) and daunomycin (DNM) to calf thymus DNA, provides reproducible binding data only when moderate drug/DNA molar ratios are used in the assays. Under these conditions, the fraction of DNA-bound drug, in equilibrium with free anthracycline, which can be reliably detected, ranged from 40-60% to 80-95% of the total added drug, depending upon ionic strength and temperature. Use of the neighbour exclusion model adequately fits such data and predicts that (i) the affinity of ADM for binding to the DNA is always higher than that corresponding to DNM, under similar experimental conditions, (ii) the binding constant for both drugs exhibits a strong salt and temperature dependence, and (iii) the exclusion parameter, indicative of the size of the anthracycline binding sites on the DNA, equals 3.1 +/- 0.4 and 3.3 +/- 0.4 base pairs for ADM and DNM, respectively, and is independent of salt concentration. The salt and temperature dependence of the binding constant is used to estimate the thermodynamic parameters involved in the interaction of the drugs with the DNA. Binding of the drugs is an exothermic process and the binding free energy arises primarily from a large negative enthalpy which, as the entropy, strongly depends upon ionic strength, and is much larger than predicted by polyelectrolyte theory. The enthalpy and entropy changes observed, appear to compensate each other over the entire range of salt concentrations used, and may arise from a complex variety of contributions, including salt-induced changes in secondary structure of the DNA, as indicated by circular dichroism techniques.
Similar articles
-
Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on interaction of daunomycin with deoxyribonucleic acid.Biochemistry. 1982 Aug 17;21(17):3933-40. doi: 10.1021/bi00260a005. Biochemistry. 1982. PMID: 7126524
-
Thermodynamics of the interaction of daunomycin with DNA.Biophys Chem. 1977 Apr;6(3):363-8. doi: 10.1016/0301-4622(77)85017-5. Biophys Chem. 1977. PMID: 880347
-
The interaction of daunorubicin and doxorubicin with DNA and chromatin.Biochim Biophys Acta. 1980 Apr 30;607(2):206-14. doi: 10.1016/0005-2787(80)90073-8. Biochim Biophys Acta. 1980. PMID: 7370266
-
Thermodynamics of the interaction of aristololactam-beta-D-glucoside with DNA. Ionic strength dependence of enthalpy and entropy.Biochem Pharmacol. 1990 Apr 1;39(7):1181-6. doi: 10.1016/0006-2952(90)90260-r. Biochem Pharmacol. 1990. PMID: 2322302
-
Thermodynamics of the interaction of berberine with DNA.Biochem Pharmacol. 1993 Nov 2;46(9):1665-7. doi: 10.1016/0006-2952(93)90337-v. Biochem Pharmacol. 1993. PMID: 8240423
Cited by
-
Unraveling the interaction between doxorubicin and DNA origami nanostructures for customizable chemotherapeutic drug release.Nucleic Acids Res. 2021 Apr 6;49(6):3048-3062. doi: 10.1093/nar/gkab097. Nucleic Acids Res. 2021. PMID: 33660776 Free PMC article.
-
Cooperative effects on the formation of intercalation sites.Nucleic Acids Res. 2004 Sep 1;32(15):4696-703. doi: 10.1093/nar/gkh788. Print 2004. Nucleic Acids Res. 2004. PMID: 15342790 Free PMC article.
-
Treatment of acquired drug resistance in multiple myeloma by combination therapy with XPO1 and topoisomerase II inhibitors.J Hematol Oncol. 2016 Aug 24;9(1):73. doi: 10.1186/s13045-016-0304-z. J Hematol Oncol. 2016. PMID: 27557643 Free PMC article. Clinical Trial.
-
Chromatin as a target for the DNA-binding anticancer drugs.Subcell Biochem. 2007;41:145-89. doi: 10.1007/1-4020-5466-1_8. Subcell Biochem. 2007. PMID: 17484128 Free PMC article. Review.
-
Menogaril, an anthracycline compound with a novel mechanism of action: cellular pharmacology.Jpn J Cancer Res. 1990 Aug;81(8):842-9. doi: 10.1111/j.1349-7006.1990.tb02654.x. Jpn J Cancer Res. 1990. PMID: 2144516 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources